/CANL
CANL Stock - CannLabs, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
47
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CANL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta5.59
52W High$0.01
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $4.39M | $3.18M | $2.77M | $2.50M | $1.36M |
| Gross Profit | $2.06M | $1.70M | $1.25M | $1.45M | $478,114 |
| Gross Margin | 47.0% | 53.4% | 45.1% | 57.9% | 35.0% |
| Operating Income | $872,236 | $714,300 | $522,100 | $804,280 | $-3,187,660 |
| Net Income | $869,171 | $712,797 | $520,571 | $803,582 | $-1,584,218 |
| Net Margin | 19.8% | 22.4% | 18.8% | 32.2% | -116.1% |
| EPS | $0.00 | $0.00 | $0.00 | $0.01 | $-0.03 |
Company Overview
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. is based in Denver, Colorado.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CANLBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.00
Q4 2022
EPS Surprise History
Q1 21
No data
Q2 21
No data
Q3 21
No data
Q4 21
No data
Q1 22
No data
Q3 22
No data
Q4 22
No data
Q4 22
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | May 29, 2024 | — | — | — | — |
Q2 2024 | May 1, 2024 | — | — | — | — |
Q4 2022 | Dec 30, 2022 | — | $0.00 | — | — |
Q4 2022 | Nov 19, 2022 | — | $0.00 | — | — |
Q3 2022 | Sep 29, 2022 | — | $0.00 | — | — |
Q1 2022 | Mar 30, 2022 | — | $0.00 | — | — |
Q4 2021 | Dec 30, 2021 | — | $0.00 | — | — |
Q3 2021 | Sep 29, 2021 | — | $0.00 | — | — |
Q2 2021 | Jun 29, 2021 | — | $0.00 | — | — |
Q1 2021 | Mar 30, 2021 | — | $0.00 | — | — |
Q1 2015 | Mar 31, 2015 | — | $-0.00 | — | — |
Q4 2014 | Dec 31, 2014 | — | $-0.01 | — | — |
Q3 2014 | Sep 30, 2014 | — | $-0.01 | — | — |
Q2 2014 | Jun 30, 2014 | — | $-0.01 | — | — |
Q1 2014 | Mar 31, 2014 | — | $-0.00 | — | — |
Q4 2013 | Dec 31, 2013 | — | $-0.73 | — | — |
Q4 2013 | Dec 31, 2013 | — | $-0.00 | — | — |
Q3 2013 | Sep 30, 2013 | — | $-0.00 | — | — |
Q2 2013 | Jun 30, 2013 | — | $-0.00 | — | — |
Q4 2012 | Dec 31, 2012 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CANL
What is CANL's current stock price?
CannLabs, Inc. (CANL) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for CANL?
No analyst price targets are currently available for this stock.
What sector is CannLabs, Inc. in?
CannLabs, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is CANL's market cap?
CannLabs, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does CANL pay dividends?
No, CannLabs, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADVT
Advantis Corp.
$0.00
Mkt Cap: $0.0B
BBBT
Black Bird Biotech, Inc.
$0.00
Mkt Cap: $0.0B
EAPH
Parallel Industries Inc.
$0.00
Mkt Cap: $0.0B
GCAN
The Greater Cannabis Company, Inc.
$0.08
Mkt Cap: $0.0B
GREH
Green Rain Energy Holdings Inc.
$0.00
Mkt Cap: $0.0B
INLB
Item 9 Labs Corp.
$0.00
Mkt Cap: $0.0B
REZNF
Street Capital Inc.
$0.00
Mkt Cap: $0.0B
TRCNF
Transnational Cannabis Ltd.
$0.00
Mkt Cap: $0.0B
WRHLF
Love Hemp Group Plc
$0.00
Mkt Cap: $0.0B
XTXXF
Adastra Holdings Ltd.
$0.02
Mkt Cap: $0.0B
Explore stocks similar to CANL for comparison